Bleakley Financial Group’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$738K Sell
29,185
-2,957
-9% -$69.9K 0.01% 723
2026
Q1
$702K Buy
32,142
+891
+3% +$20.7K 0.01% 588
2025
Q4
$727K Sell
31,251
-726
-2% -$17.5K 0.01% 535
2025
Q3
$905K Buy
31,977
+161
+0.5% +$4.28K 0.02% 438
2025
Q2
$700K Buy
31,816
+1,671
+6% +$36.5K 0.02% 449
2025
Q1
$702K Buy
30,145
+1,529
+5% +$39.1K 0.02% 389
2024
Q4
$822K Sell
28,616
-2,445
-8% -$73.2K 0.02% 467
2024
Q3
$922K Buy
31,061
+1,740
+6% +$54K 0.03% 423
2024
Q2
$988K Buy
29,321
+1,179
+4% +$40.7K 0.03% 421
2024
Q1
$1.02M Buy
28,142
+4,058
+17% +$140K 0.03% 422
2023
Q4
$787K Buy
24,084
+273
+1% +$8.43K 0.03% 465
2023
Q3
$775K Buy
23,811
+831
+4% +$26.6K 0.03% 436
2023
Q2
$672K Buy
22,980
+3,616
+19% +$99.7K 0.02% 512
2023
Q1
$543K Sell
19,364
-932
-5% -$26.3K 0.02% 547
2022
Q4
$553K Buy
+20,296
New +$542K 0.02% 531

Other funds holding GNTX

Bleakley Financial Group's GNTX Position: Q2 2026 in Review

Bleakley Financial Group reduced its Gentex (GNTX) stake by 9.2% in Q2 2026, selling an estimated $69.9K and leaving 29,185 shares worth $738K. The position accounts for 0.01% of the portfolio, ranked #723.

Bleakley Financial Group first reported a position in GNTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.02M in Q1 2024. 528 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Bleakley Financial Group held 29,185 shares of Gentex worth $738K as of Q2 2026.
  • Bleakley Financial Group sold 2,957 Gentex shares in Q2 2026, an estimated $69.9K.
  • Gentex made up 0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #723 holding.
  • Bleakley Financial Group first reported a position in Gentex in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Gentex position peaked at $1.02M in Q1 2024.
  • 528 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.